← FDA DRUG APPROVALS

FDA NDA · NDA009489

PATHILON

Sponsor: LEDERLE

APPLICATION
NDA009489
TYPE
NDA
ORIGINAL APPROVAL
1954-09-15
LATEST ACTION
1991-11-07
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

PATHILONDiscontinued
TRIDIHEXETHYL CHLORIDE 25MG · TABLET · ORAL

Approval history

1991-11-07Manufacturing (CMC) · Supplement 25 · standardAP
1990-01-09Labeling · Supplement 24 · standardAP
1989-03-27Labeling · Supplement 23 · standardAP
1988-09-28Manufacturing (CMC) · Supplement 22 · standardAP
1987-07-16Labeling · Supplement 21 · standardAP
1954-09-15Type 1 - New Molecular Entity · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →